Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terazosin Sequential Therapy for Refractory Heart Failure
ChiCTR-IPR-16009291Phase 4Completed
- Sponsor
- Tianjin Jizhou District People's Hospital
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of terazosin in heart failure (HF) (2 arms), sponsored by Tianjin Jizhou District People's Hospital. Primary endpoints: Heart function, Left ventricular ejection fraction and 2 more. Started Sep 2011; status: completed.
02
Drugs
terazosin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ChiCTR-IPR-16009291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009291.